Advancements Shaping the CD47 Targeting Therapeutics Market
The rising demand for CD47 targeting therapeutics is reshaping the treatment landscape for cancer patients worldwide. A surge in cancer cases, particularly in the United States, where over 1.9 million new cases are diagnosed annually, is propelling the CD47 Targeting Therapeutics Market demand to unprecedented levels. The market, anticipated to grow from USD 2.41 billion in 2024 to USD 23.3...
0 Commentaires 0 Parts 88 Vue 0 Aperçu